截至2026年1月30日收盘，锐捷网络(301165)报收于81.17元，上涨3.74%，换手率1.1%，成交量8.76万 手，成交额7.03亿元。 投资者： 什么时候发布业绩预告？ 董秘： 尊敬的投资者您好，公司不涉及法定应当披露业绩预告的情况。敬请您关注公司后需披露的 《2025年度报告》，了解公司全年经营情况。感谢您的关注。 当日关注点 来自交易信息汇总：1月30日主力资金净流入2243.14万元，显示主力对锐捷网络的积极介入。 交易信息汇总资金流向 董秘最新回复 投资者： 公司智能医疗相关业务（含全光网络、云桌面、Wi-Fi 7零漫游等方案）2025年营收、占比及 同比增速分别是多少？服务5000余家医院的合作中，2025年新增三甲医院/百强医院客户数、大额订单 （如≥1000万元）数量有多少？ 董秘： 尊敬的投资者您好，公司在医疗行业的整体收入、增速、大额订单等未达到法定披露要求，且 订单情况涉及商业秘密，关于2025年度公司整体经营业绩请关注公司后续披露的年度报告。公司的医疗 网络解决方案已服务全国5000余家医院，覆盖60余家百强医院与800余家三甲医院。根据IDC2025年Q3 数据，在医疗行 ...

Group 1 - The company held its 18th meeting of the 7th Board of Directors on January 30, 2026, with all 7 directors present, and the meeting was chaired by Chairman Yang Bo [2][3] - The board approved the proposal for expected daily related transactions for 2026, with a total amount not exceeding RMB 1,681.80 million, involving transactions with the controlling shareholder Yunnan Yunnei Power Group Co., Ltd. and its subsidiaries [2][3] - The board also approved the proposal to repurchase and cancel 14,582,762 shares of restricted stock due to unmet conditions for the third release period of the 2022 restricted stock incentive plan, which represents 0.7537% of the company's total share capital [10][11][21] Group 2 - The company plans to change its registered capital from RMB 1,934,844,410 to RMB 1,920,261,648 following the repurchase and cancellation of restricted stock [43][44] - The board proposed to revise the company's articles of association accordingly, which will also require approval at the upcoming shareholders' meeting [43][44] - The company will hold its first extraordinary shareholders' meeting of 2026 on February 25, 2026, to discuss the approved proposals [50][52] Group 3 - The expected daily related transactions for 2026 include RMB 1,279.13 million for purchasing products and services, RMB 389.14 million for selling products and services, and RMB 13.53 million for rental income [34] - The company reported that the actual amount of similar transactions in 2025 was RMB 1,204.47 million, indicating an increase in expected transactions for 2026 [34][36] - The board's decision on related transactions was made with the independent directors' prior approval, ensuring compliance with regulations [34][35] Group 4 - The repurchase price for the restricted stock is set at RMB 1.54 per share, which is the same as the original grant price [24] - The total funds required for the repurchase amount to RMB 22,457,453.48, sourced from the company's own funds [25] - The cancellation of the restricted stock will not affect the company's financial status or operational results significantly [28] Group 5 - The company has ensured that all necessary approvals and legal opinions have been obtained for the repurchase and cancellation of restricted stock [29] - The company will continue to fulfill its disclosure obligations regarding the repurchase and related matters as required by law [29][30] - The board will authorize relevant personnel to handle the registration changes following the shareholders' meeting approval [45]

山东新华医疗器械股份有限公司 第十一届董事会第二十五次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚假记载、误导性陈述或者重大 遗漏负连带责任。 一、董事会会议召开情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600587 证券简称：新华医疗 编号：临2026-004 山东新华医疗器械股份有限公司（以下简称"公司"或"新华医疗"）第十一届董事会第二十五次会议于 2026年1月20日以书面或通讯方式通知全体董事，据此通知，会议于2026年1月30日在公司三楼会议室召 开。会议以现场与通讯相结合的方式召开，会议应到董事11名，实到11名，公司高级管理人员列席了会 议，会议由董事长王玉全先生主持，会议程序符合《公司法》和《公司章程》的规定。 二、董事会会议审议情况 （一）审议通过《关于换选公司董事的议案》 公司董事李孝利先生因工作调动已向公司董事会提交了书面辞职申请，申请辞去公司第十一届董事会董 事职务，根据《公司法》、《上海证券交易所股票上市规则》及《公司章程》等有关规定，经公司第十 一届董事会提名，提名赵军先生为公司新任董事。 公司董事换选后，第十一届董事会由 ...

Group 1 - Tianyuan Pet announced the convening of its fourth board meeting on January 28, 2026, in Hangzhou, Zhejiang Province [1] - The meeting reviewed the proposal to authorize the board to handle matters related to the 2026 restricted stock incentive plan [1] Group 2 - The investigation into the "Jie Wo Rui" redemption crisis on the Shuibei Gold platform revealed a 40-fold leverage bet, leading to losses as gold prices rise [1] - Investors reported that the proposed redemption plan offered only 20% of the principal, which they found unacceptable [1]

（记者 王瀚黎） 每经AI快讯，科创新源1月29日晚间发布公告称，公司第四届第十五次董事会会议于2026年1月29日在 深圳市光明区新湖街道同富裕工业园富川科技工业园2号厂房3楼会议室以现场方式召开。会议审议了 《关于调整2025年限制性股票激励计划相关事项的议案》等文件。 每经头条（nbdtoutiao）——水贝黄金平台"杰我睿"兑付危机调查：40倍杠杆对赌，金价越涨平台越 亏！老板自称"还在深圳"，投资者：兑付方案本金打两折，无法接受 ...

证券代码：603135 证券简称：中重科技 公告编号：2026-011 中重科技（天津）股份有限公司2025年限制性股票激励计划首次授予结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ■ 注：（1）上表中部分合计数与各明细数相加之和在尾数上如有差异，系四舍五入所致。 一、本次激励计划前期基本情况 中重科技（天津）股份有限公司（以下简称"公司"）2025年限制性股票激励计划（以下简称"本次激励 计划"）方式为限制性股票，股份来源为公司向激励对象定向发行的本公司人民币A股普通股股票，拟 授予的权益数量为696.77万股，占公司总股本比例为1.11%。其中，首次授予的权益数量为557.42万 股，占公司总股本比例为0.89%；预留授予的权益数量为139.35万股，占公司总股本比例为0.22%。具体 内容详见公司2025年12月11日披露于上海证券交易所官网（www.sse.com.cn）的《中重科技（天津）股 份有限公司2025年限制性股票激励计划（草案）摘要公告》（公告编号：2025-070）。 二、限制 ...

Core Viewpoint - Guangdong Hongtu Technology Co., Ltd. announced a share repurchase and cancellation of 1,553,228 restricted shares, leading to a reduction in registered capital by 1,553,228 yuan [1][2]. Group 1: Share Repurchase and Cancellation - The repurchase and cancellation of shares were approved by the company's board and the first extraordinary general meeting of shareholders in 2026 [2]. - The shares being repurchased represent approximately 0.23% of the company's total share capital prior to cancellation [2]. Group 2: Capital Change and Articles of Association Modification - Following the repurchase, the registered capital will decrease from 664,376,239 yuan to 662,823,011 yuan [3]. - The company will amend its Articles of Association to reflect the changes in registered capital, pending approval from the industrial and commercial registration authority [3]. Group 3: Creditor Rights Notification - The company notified creditors that they have 45 days from the announcement date to request debt repayment or guarantees [4]. - If creditors do not exercise their rights within the specified period, the company will proceed with the capital reduction as per legal procedures [4]. - The repurchase and capital reduction are adjustments made in accordance with the restricted stock incentive plan to maintain its integrity and protect the rights of the company and its shareholders [4].

Core Viewpoint - Shenzhen Tiande Yu Technology Co., Ltd. has approved the 2026 Restricted Stock Incentive Plan, which includes a list of incentive targets and related management measures, ensuring compliance with relevant laws and regulations [1][3]. Group 1: Announcement Details - The company held the 17th meeting of the first board and the first meeting of the second remuneration and assessment committee on January 16, 2026, to review the incentive plan [1]. - The draft of the incentive plan and related documents were disclosed on the Shanghai Stock Exchange website on January 17, 2026 [1]. Group 2: Public Disclosure and Review Process - The company publicly displayed the names and positions of the proposed incentive targets from January 16 to January 26, 2026, allowing employees to provide feedback [2]. - No objections were raised by employees during the public disclosure period [2]. Group 3: Committee Review Opinions - The remuneration and assessment committee confirmed that the individuals listed as incentive targets meet the qualifications set forth in the Company Law, Securities Law, and the company's articles of association [3]. - The committee found that the incentive targets do not fall under any disqualifying conditions as outlined in the management regulations [4]. Group 4: Eligibility of Incentive Targets - The incentive targets include directors, senior management, core technical personnel, and other key business personnel, excluding independent directors [5]. - The committee verified that the basic information of the incentive targets is accurate and does not contain any misleading or concealed information [5].

Core Viewpoint - Zhejiang Hangke Technology Co., Ltd. has conducted a self-examination report regarding insider trading related to its 2026 Restricted Stock Incentive Plan, confirming no violations of insider trading laws during the specified period [1][8]. Group 1: Insider Trading Examination - The company held a board meeting on January 6, 2026, to review the 2026 Restricted Stock Incentive Plan and disclosed relevant announcements on January 7, 2026 [1]. - The company implemented necessary confidentiality measures and registered insider information personnel in accordance with relevant laws and regulations [2]. - A total of 134 individuals involved in the incentive plan were found to have traded the company's stock during the self-examination period, with none being company directors or senior management [4]. Group 2: Trading Behavior Analysis - Among the 134 individuals, 121 traded stocks before the planning of the incentive plan began, and their actions were based on publicly disclosed information [4]. - Twelve individuals traded stocks after the planning began but before public disclosure, and they claimed their actions were based on publicly available information without knowledge of the specific details of the incentive plan [5]. - One individual, not part of the incentive plan but an insider, also traded stocks before the planning began, with actions based on personal judgment [6]. Group 3: Conclusion of the Examination - The company has established relevant systems for information disclosure and insider information management, ensuring strict confidentiality during the planning and decision-making processes [8]. - No evidence was found of insider trading or leakage of insider information related to the incentive plan during the six months prior to the announcement of the plan [8].

芯原股份公告称，2020年限制性股票激励计划预留授予第二批次第三个归属期已完成归属登记手续。本 次归属激励对象共18人，归属股票来源为向激励对象定向发行A股普通股，归属股份数量5.7万股，上市 流通日为2026年，副总裁汪志伟归属1.25万股。董事和高管任职期内每年转让股份不得超持股总数 25%，离职半年内不得转让。本次归属后公司总股本增至525,915,273股，对控制权无影响，基本每股收 益将摊薄，但对财务和经营成果无重大影响。 ...